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Abstract In order to investigate oxysterol-mediated effects on
the biliary system, we studied the effects of cholestan-3L,5K,6L-
triol (TriolC) and 7-ketocholesterol (7KC) on gallbladder
epithelial cells. We compared their cell proliferation effects in
cultured dog gallbladder epithelial cells (DGBE) to their effects
in cultured human pulmonary artery endothelial cells (HPAE).
Oxysterols inhibited cell proliferation in a dose-dependent
fashion. Oxysterols inhibited cell growth to 50% of control at
a higher dose for DGBE cells than for HPAE cells. TriolC was
more cytotoxic than 7KC. We also investigated the effect of
oxysterols on bile salt-induced mucin secretion by DGBE cells.
TriolC suppressed mucin secretion by DGBE cells, whereas 7KC
did not. These findings support the hypothesis that biliary
oxysterols affect gallbladder mucosal function. ß 2000 Feder-
ation of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
Cholesterol is essential for the formation and function of
cell membranes. Oxysterols are derived in vitro as autoxida-
tion products of cholesterol [1]. Cholesterol is also metabo-
lized to various cholesterol oxides (oxysterols) in vivo during
the production of bile acids and hormones. Many oxysterol
species have been identi¢ed in animal and human tissues [1,2]
and in plasma [3]. Oxysterols are also found in high concen-
trations in atheromatous plaques [4]. In animal experiments
oxysterols are much more atherogenic than cholesterol itself
[5]. In humans, oxysterol involvement in the initiation and
progression of atherosclerosis has been postulated.
Cholesterol and its derivatives such as bile salts are found in
high concentrations in bile. Oxysterols are postulated to be
present in high concentrations in bile, but the study of biliary
oxysterols is in its infancy. Indeed, little is known currently
about the composition and concentrations of oxysterol species
in bile. There have been no studies on the e¡ects of oxysterols
on the biliary tract. Moreover, there have been no scienti¢c
publications on oxysterols in bile in the last two decades. The
gallbladder is often regarded as a passive reservoir that stores
and concentrates bile secreted by the liver. To achieve this
function, during the storage-concentration period, the gall-
bladder epithelium is exposed to high concentrations of bile
acids, phospholipids, and cholesterol. We hypothesize that
oxysterols in bile may be involved in the pathogenesis of bili-
ary tract disease such as cholelithiasis and biliary tract can-
cers. This is analogous to oxysterols in blood, which are be-
lieved to be involved in the pathogenesis of atherosclerosis.
We have reported the long-term culturing and passaging of
normal, well-di¡erentiated gallbladder epithelial cells from the
dog [6]. These cells form electrically leak-proof monolayers
and synthesize protein and mucus glycoprotein. Mucin secre-
tion in these cells is stimulated by several secretagogues that
caused an increase in intracellular cAMP [7]. Mucin secretion
by these cells is stimulated by model bile solutions [8^10]. Bile
salts were responsible for the stimulatory e¡ect of model bile
on mucin secretion and caused a dose-dependent stimulation
of mucin secretion. In the present study, we have used dog
gallbladder epithelial (DGBE) cells as a model system to in-
vestigate the cytotoxic e¡ects of oxysterols on biliary cells, as
well as the e¡ects of oxysterols on bile salt-induced mucin
secretion. Because the composition and concentrations of bili-
ary oxysterols are currently not well de¢ned, we chose to use
the commercially available oxysterols cholestan-3L,5K,6L-triol
(TriolC) and 7-ketocholesterol (7KC) for these studies.
2. Materials and methods
2.1. Chemicals and reagents
Vitrogen was purchased from Celtrix Laboratories (Palo Alto, CA,
USA). Tissue-culture plates were from Falcon (Lincoln Park, NJ,
USA). Transwell inserts (24.5 mm diameter, 3.0 Wm pore size) were
obtained from Costar (Cambridge, MA, USA). [3H]N-acetyl-D-glucos-
amine and Na2[51Cr]O4 were purchased from ICN (Irvine, CA, USA).
TriolC, s 99% purity and 7-ketocholesterol 7KC, s 99% purity were
obtained from Steraloids (Wilton, NH, USA). Lecithin (L-K-phospha-
tidylcholine from frozen egg yolk, type V-E, approximately 99% pure)
was from Sigma Chemical Co (St. Louis, MO, USA). Cholesterol was
obtained from Sigma, and was s 99% pure. Taurocholate was from
Calbiochem (La Jolla, CA, USA), and was s 90% pure. Cell culture
medium and other reagents were obtained from Sigma.
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2.2. Isolation and culture of DGBE cells
Epithelial cells were isolated from dog gallbladder by trypsinization,
as previously described [6]. Stock cultures were grown on 60-mm Petri
dishes coated with 1 ml Vitrogen gel (1:1 mixture of Vitrogen and
medium) in Eagle’s minimum essential medium supplemented with
10% fetal calf serum, 2 mM L-glutamine, 20 mM HEPES, 100 IU/
ml penicillin, and 100 Wg/ml streptomycin. Medium was changed twice
a week and the cells were maintained in a 37‡C incubator with 5%
CO2. The cells were passaged when con£uent (every 7^10 days), using
trypsin (2.5 g/l) and EDTA (1 g/l) treatment.
2.3. Culture of normal human pulmonary artery endothelial (HPAE)
cells
HPAE cells were obtained from Clonetics (San Diego, CA, USA).
Stock cultures were grown on 60-mm Petri dishes in endothelial cell
growth medium obtained from Clonetics. Medium was changed three
times a week and the cells were maintained in a 37‡C incubator with
5% CO2. The cells were passaged when 80^90% con£uent (every 7^10
days), using trypsin (2.5 g/l) and EDTA (1 g/l) treatment.
2.4. Growth inhibition experiments
For the growth experiments, either DGBE cells or HPAE cells were
plated at a density of 30 000 cells per well on 24-well plates, and
incubated for 24 h. Subsequently, solutions of either TriolC or 7KC
in 0.5% ethanol/cell culture medium were added to triplicate wells.
48 h after adding the oxysterols, cell proliferation was measured by
a non-radioactive colorimetric method [11] using tetrazolium salts
(CellTiter 96, Promega, Madison, WI, USA), according to the man-
ufacturer’s instructions with the following modi¢cations. Tetrazolium
dye in phosphate-bu¡ered saline (PBS, 150 Wl) was added to each well.
After incubation for 4 h, 1 ml of solubilization solution was added to
each well, and the plates were incubated for another hour. The solu-
tions were then transferred to a cuvette and the optical density was
read at 570 nm, using a spectrophotometer. Cell proliferation was
expressed as a percentage of control, measured in the absence of oxy-
sterols.
2.5. 51Cr release assay
Viability of con£uent cells was quanti¢ed by measuring 51Cr release
from prelabeled cells [12]. DGBE cells were grown to con£uence on
Transwell inserts in 6-well tissue-culture plates. This allowed separate
and independent access to the apical (luminal) and basolateral (sero-
sal) compartments, and enabled simulation of luminal events mediated
by biliary components. Culture medium containing 1 WCi/ml of 51Cr
was added to the basolateral compartments of the wells. After labeling
overnight, cells were washed once with sterile PBS (pH 7.4) for 30 min,
followed by washing for another 30 min with serum-free medium.
Then, test components in 2 ml of serum-free medium were added to
either the apical or the basolateral compartments, and 2-ml aliquots
of serum-free medium were added to the other compartments. The
plates were returned to the incubator for 24 h. Cell-free supernatant
medium (500 Wl) was removed from the apical compartments for
determination of 51Cr release. 51Cr release (% maximum) was calcu-
lated as follows: (tested 51Cr counts/minute (cpm) released)/(the mean
maximum 51Cr cpm released)U100%. Maximum 51Cr release was de-
termined by incubating the cells in 2.5 mM Triton X-100. We also
calculated speci¢c 51Cr release as caused by oxysterols as follows:
speci¢c 51Cr release (%) = (tested 51Cr cpm released3the mean spon-
taneous 51Cr cpm released)/(the mean maximum 51Cr cpm relea-
sed3the mean spontaneous 51Cr cpm released)U100%. Spontaneous
51Cr release was determined by incubating the cells in serum-free
medium.
2.6. Mucin secretion assay
The mucin secretion assay was performed as described [8] with
slight modi¢cations. DGBE cells were grown to con£uence on Trans-
well inserts in 6-well tissue-culture plates. Cells were labeled overnight
(16^24 h) with 2 WCi/well [3H]N-acetyl-D-glucosamine, in medium
containing 10% (v/v) fetal calf serum. The precursor sugar was added
to the bottom compartment of the wells, exposing only the basolateral
side of the cells to the label. To remove unincorporated label, cells
were then washed with sterile PBS (pH 7.4) for 30 min, followed by
washing for another 30 min with serum-free medium. Next, 2-ml
aliquots of serum-free medium containing the test components were
added to the apical compartments and 2-ml aliquots of serum-free
medium to the basolateral compartments of the wells. The plates
were returned to the incubator. After the incubation, 1 ml of medium
was harvested from each Transwell and spun at 500Ug for 10 min to
pellet released cells. A sample (500 Wl) of the supernatant was then
mixed with 8 ml of 10% trichloroacetic acid/1% phosphotungstic acid.
This mixture was vortexed and incubated overnight at 4‡C. The cells
in the Transwells were washed once with PBS and harvested with
trypsin/EDTA. After collection, they were again washed with PBS
and spun at 500Ug for 10 min. Aliquots of the cell pellets were
sampled for protein content as described by Smith et al. [13]. The
remaining cells were treated with 10% trichloroacetic acid/1% phos-
photungstic acid, similar to the processing of the medium samples.
After precipitation overnight, the samples were spun at 1500Ug for
15 min. The resulting protein pellets were washed twice, ¢rst with 5 ml
of 10% trichloroacetic acid/1% phosphotungstic acid, then with 2 ml
of 90% ethanol. Finally the pellets were dissolved in 0.5 ml of water
and counted in 10 ml of scintillation £uid. Results were expressed as
percentage of control in cpm/mg cell protein.
2.7. Preparation of model biles
Model biles were prepared according to Kibe et al. [14]. Tauro-
cholic acid was dissolved in methanol and water (85/15 v/v), and
mixed with lecithin and cholesterol (or oxysterols) in chloroform.
The solvent was then evaporated under nitrogen gas, and the residue
was lyophilized. Model biles were stored at 370‡C until further use.
For the 51Cr release assay and the mucin secretion assays, the model
biles were dissolved in 5 ml of PBS (pH 7.4), and equilibrated over-
night at 56‡C. The model biles were diluted 1:10 in serum-free culture
medium and sterile ¢ltered through a 0.45-Wm ¢lter. The ¢nal concen-
tration of each lipid was 20 mM for taurocholic acid, 4.6 mM for
lecithin, and 1.2 mM for cholesterol or oxysterols, respectively. Their
cholesterol saturation index was 1.1. The model biles containing cho-
lesterol and those containing oxysterol were mixed in a suitable ratio
before applying these model biles to the cell culture system. The re-
sulting model bile solutions were added to the apical compartment of
the Transwell system. The treated cells were incubated for 24 h in the
incubator before harvesting of the medium and cells as described
above.
2.8. Calculation and statistics
Data are expressed as mean þ S.D. of triplicate wells in at least
three individual experiments. Analysis of variance and Student’s t-
test were used to assess the signi¢cance of di¡erences; P6 0.05 was
considered signi¢cant.
3. Results
3.1. E¡ects of oxysterols on DGBE and HPAE cell
proliferation
The e¡ects of TriolC and 7KC on cell proliferation of two
di¡erent cell lines, DGBE cells and HPAE cells, were exam-
ined. Cells were plated at equal density and cultured for 24 h
before treatment with the oxysterols. Oxysterols were added
to the cells in concentrations ranging from 1 to 100 WM. After
treatment with oxysterols for 48 h, the cell numbers were
measured by a non-radioactive colorimetric method using tet-
razolium salts [11]. Fig. 1 shows the inhibitory e¡ects of Tri-
olC and 7KC on DGBE cells (A) and HPAE cells (B), respec-
tively. The proliferation of both cell types was inhibited by the
oxysterols in a dose-dependent fashion. The concentrations at
which TriolC and 7KC inhibited cell growth to 50% of control
(IC50) were estimated at 24.2 and 60.5 WM, respectively, for
the DGBE cells. In contrast, much stronger e¡ects of both
oxysterols on the HPAE cells were observed. The IC50s of
TriolC and 7KC for the HPAE cells were estimated at 5.7
and 16.4 WM, respectively. The IC50s of both oxysterols
were about four times higher for DGBE cells than for
HPAE cells. This suggests that, when proliferating, DGBE
cells are more resistant to oxysterols than HPAE cells. Fur-
thermore, TriolC had a greater growth inhibitory e¡ect than
7KC.
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3.2. Cytotoxic e¡ects of oxysterols on con£uent cultured
DGBE cells
We next investigated the cytotoxic e¡ects of oxysterols on
con£uent DGBE cells grown on Transwell inserts. This cul-
ture system allowed separate and independent access to the
apical (luminal) and basolateral (serosal) compartments. Tri-
olC (120 or 240 WM) was dissolved in a solution of 1% etha-
nol in serum-free medium. TriolC solutions were added to
either the apical compartments or the basolateral compart-
ments of Transwells containing con£uent monolayers of
DGBE cells labeled with 51Cr. Release of 51Cr from the cells
was measured after 24 h of incubation (Table 1). No increase
in 51Cr release was observed after application of TriolC to
either the apical or basolateral compartments. At a concen-
tration of 240 WM, TriolC was oversaturated. Therefore, to
dissolve higher concentrations of oxysterols, we made model
Fig. 1. The e¡ect of oxysterols on cell growth of DGBE cells (A)
and HPAE cells (B). DGBE and HPAE cells were plated at equal
density and cultured for 24 h. Oxysterols dissolved in 0.5% ethanol/
cell culture medium were then added to the cells in concentrations
ranging from 1 to 100 WM. After 48 h of incubation cell prolifera-
tion was measured. Values are expressed as a percentage of controls
incubated without oxysterols. Circles: TriolC, squares: 7KC. Data
expressed as mean þ S.D. for three individual experiments in tripli-
cate wells (n = 9).
Table 1
51Cr release by con£uent DGBE cells treated with TriolC
Treatment 51Cr Release (% of maximum)
Control 34.1 þ 1.8
Triton X-100 100 þ 1.9
EtOH 39.0 þ 3.2
120 WM TriolC (apical) 35.6 þ 1.9
120 WM TriolC (basolateral) 33.9 þ 4.0
240 WM TriolC (apical) 35.2 þ 4.1
240 WM TriolC (basolateral) 35.3 þ 2.0
DGBE cells were grown to con£uence on Transwell inserts and la-
beled with Na2[51Cr]O4. Cells were either incubated in cell culture
medium (control), 1% ethanol in cell culture medium (EtOH) or
with TriolC dissolved in 1% ethanol/cell culture medium (120 or
240 WM). TriolC was added to either the apical or the basolateral
compartments. Maximum 51Cr release from the cells was measured
by treatment with 2.5 mM of Triton X-100. 51Cr release from the
cells was measured after 24 h of incubation. Data expressed as
mean þ S.D.
Fig. 2. Speci¢c 51Cr release by con£uent DGBE cells treated with
oxysterol-containing model biles. DGBE cells were grown to con£u-
ence on Transwell inserts and labeled with Na2[51Cr]O4. Cells were
either incubated in cell culture medium (control) or in model biles
containing 300^1200 WM TriolC or 7KC. Model biles were added to
the apical compartments of the wells only. Maximum 51Cr release
from the cells was measured by treatment with 2.5 mM Triton
X-100. 51Cr release from the cells was measured after 24 h of incu-
bation. Speci¢c 51Cr release was calculated as follows; (observed
51Cr release3spontaneous release)/(maximum release3spontaneous
release)U100 (%). Circles: TriolC, squares: 7KC. Data expressed as
mean þ S.D. for three individual experiments in triplicate wells
(n = 9).
Table 2
51Cr release by con£uent DGBE cells treated with oxysterol-contain-
ing model biles
Oxysterol concentration
(WM)
TriolC
(% of maximum)
7KC
(% of maximum)
0 28.5 þ 5.4 23.0 þ 9.8
300 30.1 þ 2.9 25.5 þ 7.4
600 42.6 þ 4.7 29.4 þ 8.3
900 90.1 þ 9.5 41.1 þ 5.1
1200 94.3 þ 9.8 82.5 þ 13.7
Control 26.6 þ 2.8 20.6 þ 4.0
Triton X-100 100 þ 6.7 100 þ 6.4
DGBE cells were grown to con£uence on Transwell inserts and la-
beled with Na2[51Cr]O4. Cells were either incubated in cell culture
medium (control) or in model biles containing 300^1200 WM TriolC.
Model biles were added to the apical compartments of the wells
only. Maximum 51Cr release from the cells was measured by treat-
ment with 2.5 mM Triton X-100. 51Cr release from the cells was
measured after 24 h of incubation. Data expressed as mean þ S.D.
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biles containing the oxysterols. Oxysterol concentrations in
model bile ranged from 300 WM (25% oxysterols, 75% choles-
terol) to 1200 WM (100% oxysterols, 0% cholesterol). These
model bile solutions were added to the apical compartments
of the Transwell system and incubated for 24 h. Table 2 shows
the 51Cr release from DGBE cells after treatment with the
model biles. Model biles containing less than 300 WM TriolC
or those containing less than 600 WM 7KC did not cause an
increase of 51Cr release from the cells. At higher concentra-
tions of oxysterols, 51Cr release increased in a dose-dependent
fashion. Furthermore, the speci¢c 51Cr release as caused by
oxysterols was evaluated (Fig. 2). The concentrations at which
oxysterols caused 50% of speci¢c 51Cr release were estimated
at 709 WM (TriolC) and 1079 WM (7KC), respectively.
3.3. The e¡ects of oxysterol-containing model biles on mucin
secretion by cultured DGBE cells
Our previous studies [9^11] have consistently shown that
model biles induce mucin secretion by DGBE cells. This stim-
ulatory e¡ect was caused by bile salts. Therefore, we examined
the e¡ects of oxysterol-containing model biles on mucin secre-
tion by cultured DGBE cells. The concentrations of oxysterols
in model biles ranged from 6 to 360 WM. Cytotoxic e¡ects
were not observed at these concentrations as previously as-
sessed by the 51Cr release assay. Model bile containing cho-
lesterol alone was used as a control. The basal mucin secretion
by DGBE cells (treated with serum-free medium) was
60.5 þ 10.6% of control. Table 3 shows the mucin secretion
by DGBE cells treated with model biles containing TriolC
and 7KC. At low concentrations of TriolC (6 12 WM), mucin
secretion was slightly increased, but this e¡ect was not statis-
tically signi¢cant. However, TriolC at concentrations above
60 WM suppressed taurocholate-induced mucin secretion in a
dose-dependent fashion. At concentrations of 240 WM and
higher, mucin secretion was maximally inhibited, but still re-
mained higher than basal secretion. In contrast, mucin secre-
tion remained unaltered after treatment with model biles con-
taining 7KC.
4. Discussion
Oxysterols have multiple biological activities including in-
hibiting cholesterol synthesis [15], membrane insertion [16,17],
immunosuppression [18^21], modifying arachidonic acid me-
tabolism [22,23], augmenting cell permeability [24], inhibiting
intercellular communications [25] and modulating the activity
of membrane-bound enzymes [26]. Cytotoxic e¡ects of oxy-
sterols on di¡erent cell types have also been described [27^31].
Oxysterols induce apoptosis in di¡erent types of cells [32^34].
Some oxysterols, such as 27-hydroxycholesterol, 7KC, 7L-hy-
droxycholesterol and 7K-hydroxycholesterol have been identi-
¢ed in human atherosclerotic plaques [4]. Since these oxyster-
ols are synthesized in human liver [35^37], they might be
secreted into the biliary tract. Recently, we have found 4,6-
cholestadiene-3-one and 4-cholestene-3-one in human gall-
bladder bile [38]. Other unde¢ned oxysterols were also de-
tected. Moreover, oxysterol contents as high as 70% of total
sterol were found in pigment gallstones.
The e¡ects of oxysterols on biliary epithelial cells have not
been studied. Gallbladder epithelial cells, especially on the
luminal surface, are exposed to a high concentration of lipids,
and therefore probably oxysterols, in bile. We hypothesize
that oxysterols may a¡ect biliary epithelial cell physiology
and may be involved in the pathogenesis of biliary tract dis-
ease, such as gallstone disease and biliary tract cancer. In the
absence of any further physiological information, we have
begun mechanistic studies on the e¡ects of oxysterols on bili-
ary epithelial cells. We have investigated the cytotoxicity of
two commercially available oxysterols, TriolC and 7KC, on
gallbladder epithelial cells and their e¡ects on mucin secretion,
one of the most important functions of gallbladder epithelial
cells.
We studied the e¡ects of oxysterols on DGBE cells and
HPAE cells during cell proliferation. The concentrations at
which TriolC and 7KC inhibited cell growth to 50% of control
were approximately four times higher for DGBE cells than for
HPAE cells. The sensitivity of the cells to oxysterols might
vary in both cell types, as described by other investigators
[27^34]. Since gallbladder epithelial cells are exposed to high
concentrations of lipids in vivo, this might partially explain
the increased relative resistance of these cells to the e¡ects of
oxysterols. Furthermore, the IC50 for 7KC was 2.5^2.9 times
higher than that for TriolC for both cell lines. Zhou et al.
reported that TriolC has a greater growth inhibitory e¡ect
than 7KC on human arterial smooth muscle cells [39]. There-
fore, in addition to the dose-dependency, a structure^function
relationship may also a¡ect the oxysterol-induced e¡ects on
cell proliferation.
We also examined the cytotoxic e¡ect of oxysterols on con-
£uent, non-proliferating DGBE cells. Con£uent DGBE cells
are highly polarized by scanning electron microscopy [6].
Growing these cells on the Transwell insert system allows
separate and independent access to the apical (luminal) and
basolateral (serosal) compartments, due to the formation of a
leak-tight monolayer [8]. We used a 51Cr release assay for
evaluating the cytotoxicity of oxysterols on this culture sys-
tem. No cytotoxic e¡ects were observed with concentrations
up to 240 WM TriolC in aqueous solution. Subsequently,
DGBE cells were treated with model biles containing oxyster-
ols. An increase in 51Cr release was observed at concentra-
tions s 300 WM TriolC and s 600 WM 7KC. The concentra-
Table 3
Mucin secretion by DGBE cells treated with oxysterol-containing
model biles
Concentration
(WM)
TriolC
(% of control)
7KC
(% of control)
6 113.8 þ 22.8 112.2 þ 21.7
12 115.6 þ 28.9 98.2 þ 13.4
60 98.1 þ 25.7 97.6 þ 17.3
120 77.6 þ 6.5** 93.6 þ 10.5
240 81.6 þ 7.9** 95.4 þ 10.6
360 83.8 þ 8.1** 93.4 þ 6.6
Cholesterol 100 þ 10.6 100 þ 11.2
Medium 60.5 þ 10.6 62.9 þ 12.0
DGBE cells were grown to con£uence on Transwell inserts and la-
beled with [3H]N-acetyl-D-glucosamine. Cells were either incubated
in cell culture medium (Medium), model bile containing cholesterol
only (Cholesterol) or in model biles containing 6^360 WM TriolC or
7KC. Model biles were added to the apical compartments of the
wells only. Mucin secretion was measured after 24 h of incubation.
Data expressed as mean þ S.D. **; Signi¢cant di¡erence between
cholesterol model bile and oxysterol model bile by Student’s t-test
(P6 0.01).
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tions of oxysterols at which 50% of speci¢c 51Cr release oc-
curred were more than 15 times higher than the IC50 of oxy-
sterols for proliferating DGBE cells. Although the methods
for assessment of cytotoxicity were di¡erent between prolifer-
ating cells and con£uent cells, it is likely that the cytotoxic
susceptibility to oxysterols depends on the proliferation status
of the cell. Proliferation of biliary epithelial cells in vivo might
be slow, just like the con£uent cells in the cell culture system.
Therefore, these results suggest that gallbladder epithelial cells
are very resistant to oxidized lipids in vivo.
Mucin secretion is an important function of epithelial cells.
Secreted mucin protects epithelial cell membranes from harm-
ful agents [40]. Mucin hypersecretion has long been implicated
in the formation of cholesterol gallstones [41]. We have pre-
viously shown that model biles and bile salts induce mucin
secretion by DGBE cells [8^10] without any associated cyto-
toxicity. One explanation for increased mucin secretion by the
gallbladder in vivo may be mediation by oxysterols. However,
in the present studies TriolC actually suppressed taurocholate-
induced mucin secretion, whereas 7KC did not a¡ect it. Tri-
olC, at concentrations between 120 and 360 WM, suppressed
mucin secretion dose-dependently. At higher concentrations
of TriolC (s 240 WM) the inhibition of mucin secretion was
maximal, although the level of mucin secretion was still higher
than basal secretion. These results could indicate that TriolC
did not directly inhibit the mucin secretion as stimulated by
taurocholate. If TriolC inhibits the mucin secretion pathway
stimulated by taurocholate, mucin secretion would be ex-
pected to decrease to basal secretion in a dose-dependent
fashion. Therefore, TriolC may suppress mucin secretion via
an alternative mechanism. Oxysterols insert into cell mem-
branes and decrease membrane £uidity [16]. The decrease of
membrane £uidity causes tightening of membrane packing.
This may inhibit mucin granule exocytosis. We have tested
the e¡ect of oxysterols on mucin secretion in only one model
bile system. The stimulatory mechanism of mucin secretion by
taurocholate also applies to other bile salts, and likewise the
suppressive e¡ects on bile salt-induced mucin secretion by
TriolC. Currently little information is available on the species
and concentrations of oxysterols in bile. The present study
consists of short-term experiments with relatively high concen-
trations of oxysterols. The kinetics of oxysterol^cell mem-
brane interactions remain unexplored. However, considering
that in vivo the gallbladder epithelium is in continuous con-
tact with cholesterol (and oxysterols), we think that even at
lower concentrations of oxysterols in bile, it is possible that
long-term exposure to oxysterols alters cell membrane struc-
ture and cellular function.
The choice of oxysterols and their concentrations are justi-
¢ed for the following reasons. TriolC and 7KC are present in
human hepatic bile. TriolC concentration ranged from 18 to
387 nM; 7KC concentration ranged from 4 to 1800 nM
(Yoshida, T., unpublished observations). As these measure-
ments were performed in hepatic bile, and as lipid concentra-
tions in gallbladder bile can be 10-fold or more higher, we
estimate that gallbladder bile concentrations of TriolC and
7KC could be 4 and 20 WM, respectively. While these concen-
trations are at the lower end of the range used for our studies,
numerous other species of oxysterols are present in human
bile samples. For example, 7K-hydroxycholesterol, 7-L-hy-
droxycholesterol, 7-keto-cholesterol, TriolC, and other oxy-
sterol species are present (Yoshida, T, unpublished observa-
tions). Therefore, the total concentration of oxysterols is likely
to be present in the range that we studied. Finally, local con-
centrations of oxysterols in the vicinity of the apical mem-
brane of gallbladder epithelial cells may be much higher
than what can be measured in gallbladder and hepatic bile
due to gallbladder stasis. Hence, speci¢c interactions at the
cellular level likely occur in the presence of oxysterols at high-
er concentrations than can be measured. Due to these consid-
erations, concentrations of TriolC and 7KC in the micromolar
range were used.
These results support a model of wide-ranging oxysterol
e¡ects on gallbladder epithelial cells in the setting of in£am-
mation. The high concentrations of cholesterol in bile are
subject to oxidative damage leading to the formation of oxy-
sterols. Such oxidative damage may occur when in£ammatory
cells are activated in the biliary system, as would occur with
infection. This would lead to bacterial^neutrophil^cholesterol
interactions, leading to the formation of oxysterols. Oxyster-
ols, in turn, would have far reaching e¡ects on gallbladder
epithelial cell function, including e¡ects on cell proliferation,
cytotoxicity and mucin secretion. The suppression of mucin
secretion by certain oxysterols may be a further route to gall-
bladder epithelial cell injury. The e¡ects of oxysterols on cell
proliferation and cytotoxicity may have implications for the
development of gallbladder cancer.
In conclusion, we have for the ¢rst time studied the e¡ects
of oxysterols on gallbladder epithelial cells. We found that
oxysterols have cytotoxic e¡ects on DGBE cells and that these
e¡ects were dependent on the proliferation status of the cells.
Moreover, oxysterols with di¡erent structures had varying
e¡ects on the DGBE cells. TriolC was more cytotoxic than
7KC. TriolC also suppressed taurocholate-induced mucin se-
cretion by the cells, whereas 7KC did not. We suggest that the
cytotoxic e¡ects of oxysterols in general and the speci¢c de-
crease in mucin secretion in particular, as caused by TriolC,
might have important implications in the pathophysiology of
biliary tract diseases. Further research into the role of oxy-
sterols in the biliary tract therefore seems warranted.
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